Comparing Imatinib Standard Dose With Imatinib High Dose Induction in Pretreated Chronic Myeloid Leukemia (CML) Patients in Chronic Phase
Clinical trial NCT00327262 · UNKNOWN
Trial details
- NCT number
- NCT00327262
- Sponsor
- Central European Leukemia Study Group
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.